HNRNPD and hepatocellular carcinoma: On the other hand, the interaction between HNRNPD and circLARP1B could be blocked by ODN‐AS, and the potential effects of ODN‐AS in lipid metabolism, HCC metastasis, and even therapeutics could be further investigated.